Short answer · Medically reviewed summary · Last updated: 2023-07-13
X-linked Hypophosphatemia (XLH) is a rare genetic disorder characterized by low levels of phosphate in the blood. It is estimated to affect approximately 1 in 20,000 individuals worldwide, making it a relatively uncommon condition. XLH is caused by mutations in the PHEX gene, which is located on the X chromosome.
1 people with X-linked Hypophosphatemia (XLH) have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of X-linked Hypophosphatemia (XLH)?
Prevalence of X-linked Hypophosphatemia (XLH): how many people are affected worldwide, differences by sex and region, with sources.
X-linked Hypophosphatemia (XLH) is a rare genetic disorder characterized by low levels of phosphate in the blood. It is estimated to affect approximately 1 in 20,000 individuals worldwide, making it a relatively uncommon condition.
XLH is caused by mutations in the PHEX gene, which is located on the X chromosome. As a result, the disorder primarily affects males, although females can also be affected, albeit with milder symptoms.
The prevalence of XLH may vary among different populations and regions. However, it is generally considered to be a rare condition. The exact number of individuals with XLH is difficult to determine due to underdiagnosis and varying degrees of symptom severity.
Common symptoms of XLH include short stature, bowed legs, dental problems, and bone deformities. Early diagnosis and appropriate management are crucial to minimize the impact of the disorder on an individual's quality of life.
Research and advancements in genetic testing have improved our understanding of XLH, leading to better diagnosis and treatment options. Ongoing efforts to raise awareness and improve access to care are essential for supporting individuals and families affected by this rare genetic disorder.
Posted Aug 9, 2017 by Felipe Zúñiga 2650
